<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00747227</url>
  </required_header>
  <id_info>
    <org_study_id>BBLK-102-PRSM</org_study_id>
    <nct_id>NCT00747227</nct_id>
  </id_info>
  <brief_title>Safety and Efficacy of a Violet Visible Light Blocking Intraocular Lens (IOL)</brief_title>
  <official_title>Clinical Evaluation of a Modified Light Transmission IOL</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Abbott Medical Optics</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Abbott Medical Optics</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the safety and effectiveness of a new
      investigational modified light transmission monofocal intraocular lens compared to a
      conventional intraocular lens (IOL).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigational IOL will be found to be safe and effective with respect to visual acuity,
      color vision, contrast sensitivity and complications and will be similar to results for the
      ZA9003 control eyes. Complication rates and adverse event rates will be within the FDA grid
      for posterior chamber IOLs.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2006</start_date>
  <completion_date type="Actual">June 2009</completion_date>
  <primary_completion_date type="Actual">March 2009</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Best Corrected Distance Visual Acuity</measure>
    <time_frame>One year</time_frame>
    <description>Snellen Equivalent visual acuity of 20/40 or better</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Uncorrected Distance Visual Acuity</measure>
    <time_frame>One Year</time_frame>
    <description>Snellen Equivalent of 20/40 or better at one year</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Contrast Sensitivity</measure>
    <time_frame>4-6 months</time_frame>
    <description>Contrast sensitivity is the measurement of how faded an image may become before it can clearly be seen. Contrast sensitivity was measured in photopic and mesopic conditions at the following spatial frequencies: 3.0, 6.0, 12.0, and 18 cpd (cycles per degree). Contrast sensitivity is measured in log units. A higher value for the logarithmic units translates to better contrast sensitivity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subject Satisfaction - Subjects Satisfied With Overall Eyesight Rated as &quot;Good&quot; or &quot;Excellent&quot;.</measure>
    <time_frame>One Year</time_frame>
    <description>Subjects indicating a subjective response to a multiple choice question, &quot;At the present time, would you say your eyesight using both eyes (with glasses or contact lenses, if you wear them) is excellent, good, fair, poor, or very poor or are you completely blind?&quot;, on a multi-item questionnaire administered by interviewer to determine subject satisfaction with their overall visual outcome at the one year visit.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">250</enrollment>
  <condition>Cataract</condition>
  <arm_group>
    <arm_group_label>ZV9003</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>modified light transmission intraocular lens</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ZA9003</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>monofocal acrylic intraocular lens</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>modified light transmission intraocular lens</intervention_name>
    <description>violet visible light blocking acrylic intraocular lens</description>
    <arm_group_label>ZV9003</arm_group_label>
    <other_name>ZV9003</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>monofocal acrylic intraocular lens</intervention_name>
    <description>conventional hydrophobic acrylic intraocular lens</description>
    <arm_group_label>ZA9003</arm_group_label>
    <other_name>ZA9003</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18 years of age or older

          -  Bilateral cataracts for which phacoemulsification extraction and posterior IOL
             implantation has been planned

          -  Visual potential in both eyes of 20/30 Snellen or better after cataract removal and
             IOL implantation

          -  Preoperative corneal astigmatism of 1.5 diopters or less

        Exclusion Criteria:

          -  Use of systemic or ocular medications that may affect vision

          -  Uncontrolled systemic or recurrent ocular disease

          -  Requiring an intraocular lens &lt;15.0 or &gt;26.0 diopters

          -  Abnormal results with the Farnsworth-Munsell D-15 and/or Ishihara color plates

          -  History of ocular trauma or prior ocular surgery

          -  Known pathology that may affect visual acuity or visual field

          -  Corneal abnormalities

          -  Pupil abnormalities

          -  Capsule or zonular abnormalities
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Roger F. Steinert, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, Irvine, Dept. of Ophthalmology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Patrick Aiello, M.D.</name>
      <address>
        <city>Scottsdale</city>
        <state>Arizona</state>
        <zip>85054</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Randall E. Cole, M.D.</name>
      <address>
        <city>Rogers</city>
        <state>Arkansas</state>
        <zip>72756</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Aron Rose, M.D.</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06510</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Y. Ralph Chu, M.D.</name>
      <address>
        <city>Bloomington</city>
        <state>Minnesota</state>
        <zip>55420</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Steven Silverstein, M.D.</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64133</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jon-Marc Weston, M.D.</name>
      <address>
        <city>Roseburg</city>
        <state>Oregon</state>
        <zip>97470</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>William Christie, M.D.</name>
      <address>
        <city>Cranberry Township</city>
        <state>Pennsylvania</state>
        <zip>16066</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mark Blecher, M.D.</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19148</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Robert L. Bahr, M.D.</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02906</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vance Thompson, M.D.</name>
      <address>
        <city>Sioux Falls</city>
        <state>South Dakota</state>
        <zip>57105</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jay Rudd, M.D.</name>
      <address>
        <city>Lacey</city>
        <state>Washington</state>
        <zip>98503</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 3, 2008</study_first_submitted>
  <study_first_submitted_qc>September 4, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 5, 2008</study_first_posted>
  <results_first_submitted>March 4, 2011</results_first_submitted>
  <results_first_submitted_qc>October 6, 2011</results_first_submitted_qc>
  <results_first_posted type="Estimate">November 11, 2011</results_first_posted>
  <last_update_submitted>October 6, 2011</last_update_submitted>
  <last_update_submitted_qc>October 6, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 11, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cataract</keyword>
  <keyword>monofocal</keyword>
  <keyword>intraocular lens</keyword>
  <keyword>acrylic</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>250 subjects from normal cataract populations who were undergoing primary phacoemulsification with lens implantation and did not have any other visually significant ocular pathologies were selected at 12 investigation sites across the country</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>ZV9003 Intraocular Lens</title>
          <description>modified light transmission intraocular lens</description>
        </group>
        <group group_id="P2">
          <title>ZA9003 Intraocular Lens</title>
          <description>monofocal acrylic intraocular lens</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="126"/>
                <participants group_id="P2" count="124"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="120"/>
                <participants group_id="P2" count="120"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Illness</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>ZV9003 Intraocular Lens</title>
          <description>modified light transmission intraocular lens</description>
        </group>
        <group group_id="B2">
          <title>ZA9003 Intraocular Lens</title>
          <description>monofocal acrylic intraocular lens</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="126"/>
            <count group_id="B2" value="124"/>
            <count group_id="B3" value="250"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="73.3" spread="8.0"/>
                    <measurement group_id="B2" value="71.5" spread="8.0"/>
                    <measurement group_id="B3" value="72.4" spread="8.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;60 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 60 and 69 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="35"/>
                    <measurement group_id="B2" value="41"/>
                    <measurement group_id="B3" value="76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 70 and 79 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="57"/>
                    <measurement group_id="B2" value="54"/>
                    <measurement group_id="B3" value="111"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=80</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                    <measurement group_id="B2" value="21"/>
                    <measurement group_id="B3" value="51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="78"/>
                    <measurement group_id="B2" value="68"/>
                    <measurement group_id="B3" value="146"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="48"/>
                    <measurement group_id="B2" value="56"/>
                    <measurement group_id="B3" value="104"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="126"/>
                    <measurement group_id="B2" value="124"/>
                    <measurement group_id="B3" value="250"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Best Corrected Distance Visual Acuity</title>
        <description>Snellen Equivalent visual acuity of 20/40 or better</description>
        <time_frame>One year</time_frame>
        <population>One subject was excluded from the analysis because the ZV9003 lens was implanted in the first eye and the ZA900 lens was implanted in the second eye. All subjects in the outcomes analysis had the same lens in both eyes.</population>
        <group_list>
          <group group_id="O1">
            <title>ZV9003 Intraocular Lens</title>
            <description>modified light transmission intraocular lens</description>
          </group>
          <group group_id="O2">
            <title>ZA9003 Intraocular Lens</title>
            <description>monofocal acrylic intraocular lens</description>
          </group>
        </group_list>
        <measure>
          <title>Best Corrected Distance Visual Acuity</title>
          <description>Snellen Equivalent visual acuity of 20/40 or better</description>
          <population>One subject was excluded from the analysis because the ZV9003 lens was implanted in the first eye and the ZA900 lens was implanted in the second eye. All subjects in the outcomes analysis had the same lens in both eyes.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="119"/>
                <count group_id="O2" value="120"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="119"/>
                    <measurement group_id="O2" value="120"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Contrast Sensitivity</title>
        <description>Contrast sensitivity is the measurement of how faded an image may become before it can clearly be seen. Contrast sensitivity was measured in photopic and mesopic conditions at the following spatial frequencies: 3.0, 6.0, 12.0, and 18 cpd (cycles per degree). Contrast sensitivity is measured in log units. A higher value for the logarithmic units translates to better contrast sensitivity.</description>
        <time_frame>4-6 months</time_frame>
        <population>Binocular contrast sensitivity testing was reported for all binocular subjects with data available at the 4-6 month visit on 120 subjects in each group. One ZA9003 subject was tested at 3.0 cpd and not tested for 6.0 cpd through 18.0 cpd (mesopic and photopic). Testing for levels 6.0 through 18.0 were not reported.</population>
        <group_list>
          <group group_id="O1">
            <title>ZV9003 Intraocular Lens</title>
            <description>modified light transmission intraocular lens</description>
          </group>
          <group group_id="O2">
            <title>ZA9003 Intraocular Lens</title>
            <description>monofocal acrylic intraocular lens</description>
          </group>
        </group_list>
        <measure>
          <title>Contrast Sensitivity</title>
          <description>Contrast sensitivity is the measurement of how faded an image may become before it can clearly be seen. Contrast sensitivity was measured in photopic and mesopic conditions at the following spatial frequencies: 3.0, 6.0, 12.0, and 18 cpd (cycles per degree). Contrast sensitivity is measured in log units. A higher value for the logarithmic units translates to better contrast sensitivity.</description>
          <population>Binocular contrast sensitivity testing was reported for all binocular subjects with data available at the 4-6 month visit on 120 subjects in each group. One ZA9003 subject was tested at 3.0 cpd and not tested for 6.0 cpd through 18.0 cpd (mesopic and photopic). Testing for levels 6.0 through 18.0 were not reported.</population>
          <units>log contrast</units>
          <param>Mean</param>
          <dispersion>90% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="120"/>
                <count group_id="O2" value="120"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Mesopic condition at 3.0 cpd</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.62" lower_limit="1.58" upper_limit="1.66"/>
                    <measurement group_id="O2" value="1.62" lower_limit="1.58" upper_limit="1.66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mesopic condition at 6.0 cpd</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.65" lower_limit="1.61" upper_limit="1.69"/>
                    <measurement group_id="O2" value="1.63" lower_limit="1.58" upper_limit="1.68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mesopic condition at 12.0 cpd</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.14" lower_limit="1.07" upper_limit="1.21"/>
                    <measurement group_id="O2" value="1.17" lower_limit="1.10" upper_limit="1.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mesopic condition at 18.0 cpd</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.60" lower_limit="0.54" upper_limit="0.66"/>
                    <measurement group_id="O2" value="0.65" lower_limit="0.59" upper_limit="0.71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Photopic condition at 3.0 cpd</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.76" lower_limit="1.73" upper_limit="1.79"/>
                    <measurement group_id="O2" value="1.74" lower_limit="1.71" upper_limit="1.78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Photopic condition at 6.0 cpd</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.91" lower_limit="1.88" upper_limit="1.94"/>
                    <measurement group_id="O2" value="1.94" lower_limit="1.91" upper_limit="1.98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Photopic condition at 12.0 cpd</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.58" lower_limit="1.54" upper_limit="1.62"/>
                    <measurement group_id="O2" value="1.59" lower_limit="1.55" upper_limit="1.64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Photopic condition at 18.0 cpd</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.09" lower_limit="1.04" upper_limit="1.14"/>
                    <measurement group_id="O2" value="1.14" lower_limit="1.09" upper_limit="1.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Uncorrected Distance Visual Acuity</title>
        <description>Snellen Equivalent of 20/40 or better at one year</description>
        <time_frame>One Year</time_frame>
        <population>One subject was excluded from the analysis because the ZV9003 lens was implanted in the first eye and the ZA900 lens was implanted in the second eye. All subjects in the outcomes analysis had the same lens in both eyes.</population>
        <group_list>
          <group group_id="O1">
            <title>ZV9003 Intraocular Lens</title>
            <description>modified light transmission intraocular lens</description>
          </group>
          <group group_id="O2">
            <title>ZA9003 Intraocular Lens</title>
            <description>monofocal acrylic intraocular lens</description>
          </group>
        </group_list>
        <measure>
          <title>Uncorrected Distance Visual Acuity</title>
          <description>Snellen Equivalent of 20/40 or better at one year</description>
          <population>One subject was excluded from the analysis because the ZV9003 lens was implanted in the first eye and the ZA900 lens was implanted in the second eye. All subjects in the outcomes analysis had the same lens in both eyes.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="119"/>
                <count group_id="O2" value="120"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="110"/>
                    <measurement group_id="O2" value="116"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Subject Satisfaction - Subjects Satisfied With Overall Eyesight Rated as &quot;Good&quot; or &quot;Excellent&quot;.</title>
        <description>Subjects indicating a subjective response to a multiple choice question, &quot;At the present time, would you say your eyesight using both eyes (with glasses or contact lenses, if you wear them) is excellent, good, fair, poor, or very poor or are you completely blind?&quot;, on a multi-item questionnaire administered by interviewer to determine subject satisfaction with their overall visual outcome at the one year visit.</description>
        <time_frame>One Year</time_frame>
        <population>Two subjects in the ZV9003 group did not complete the one year questionnaire.</population>
        <group_list>
          <group group_id="O1">
            <title>ZV9003 Intraocular Lens</title>
            <description>modified light transmission intraocular lens</description>
          </group>
          <group group_id="O2">
            <title>ZA9003 Intraocular Lens</title>
            <description>monofocal acrylic intraocular lens</description>
          </group>
        </group_list>
        <measure>
          <title>Subject Satisfaction - Subjects Satisfied With Overall Eyesight Rated as &quot;Good&quot; or &quot;Excellent&quot;.</title>
          <description>Subjects indicating a subjective response to a multiple choice question, &quot;At the present time, would you say your eyesight using both eyes (with glasses or contact lenses, if you wear them) is excellent, good, fair, poor, or very poor or are you completely blind?&quot;, on a multi-item questionnaire administered by interviewer to determine subject satisfaction with their overall visual outcome at the one year visit.</description>
          <population>Two subjects in the ZV9003 group did not complete the one year questionnaire.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="118"/>
                <count group_id="O2" value="119"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="112"/>
                    <measurement group_id="O2" value="113"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>ZV9003 Intraocular Lens</title>
          <description>modified light transmission intraocular lens</description>
        </group>
        <group group_id="E2">
          <title>ZA9003 Intraocular Lens</title>
          <description>monofocal acrylic intraocular lens</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="126"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="124"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Retinal Tear requiring secondary surgical intervention</sub_title>
                <description>Secondary surgical intervention required to repair adverse event of retinal tear. Principal Investigators felt it unlikely retinal tear was lens-related and both adverse events were reported as resolved with sequelae.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="126"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="124"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="126"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="124"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>PIs may not publish or disclose study data without Sponsor's prior written approval.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Nicholas Taranatino, O.D., Head, Global Clinical Research &amp; Devlopment</name_or_title>
      <organization>Abbott medical Optics, Inc.</organization>
      <phone>866-427-8477 ext 8613</phone>
      <email>nicholas.tarantino@amo.abbott.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

